Goldman Believes Key Update On Exact Sciences Reimbursement 'Appears Imminent'


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Goldman Sachs analyst Isaac Ro issued an after-hours note Tuesday commenting on intraday price action in EXACT Sciences Corporation (NASDAQ: EXAS) shares.

With EXACT shares up more than 30 percent over the session, Ro noted "an updated USPSTF website which could have bearing on future reimbursement of Cologuard."

The analyst said, "We take no position on the Final Recommendation and potential financial impact to EXAS but note the timing comes sooner than expected. If Cologuard were included as a recommended screening method we would view the news as a positive for EXAS shares."

Ro maintained a Neutral rating on shares of EXACT Sciences.


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst ColorNewsAfter-Hours CenterAnalyst Ratings